Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4966-4972

  Rein, Alan ^a   Ott, David E ^b   Mirro, Jane ^a   Arthur, Larry O ^b   Rice, William ^b   Henderson, Louis E ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' DITHIODIPYRIDINE; ALDRITHIOL 2; BENZAMIDE DERIVATIVE; THIURAM DISULFIDE DERIVATIVE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; DNA SYNTHESIS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INACTIVATION; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

EID: 0030013723     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4966-4972.1996     Document Type: Article

References (39)

1. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
2. Aldrich Chemical Co. Dicyclopentamenthylenethiuram disulfide: material safety data sheet. Aldrich Chemical Co., Milwaukee, Wis.
3. Allain, B., M. Lapadat-Tapolsky, C. Berlioz, and J. L. Darlix. 1994. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13:973-981.
4. Bassin, R. H., N. Tuttle, and P. J. Fischinger. 1971. Rapid cell culture assay for murine leukaemia virus. Nature (London) 229:564-566.
5. Bess, J. W., Jr., P. J. Powell, H. J. Issaq, L. J. Schumack, M. K. Grimes, L. E. Henderson, and L. O. Arthur. 1992. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J. Virol. 66:840-847.
6. Budavari, S. (ed.). 1989. The Merck index. An encyclopedia of chemicals, drugs, and biologicals, 11th ed. Merck & Co., Rahway, N.J.
7. Chance, M. R., I. Sagi, M. D. Wirt, S. M. Frisbie, E. Scheuring, E. Chen, J. W. Bess, Jr., L. E. Henderson, L. O. Arthur, T. L. South, G. Perez-Alvarado, and M. F. Summers. 1992. Extended x-ray absorption line structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl. Acad. Sci. USA 89:10041-10045.
8. Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Göttlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169.
9. Dupraz, P., S. Oertle, C. Meric, P. Damay, and P.-F. Spahr. 1990. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 64:4978-4987.
10. Fu, W., R. J. Gorelick, and A. Rein. 1994. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 68:5013-5018.
11. Fu, W., and A. Rein. 1993. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67:5443-5449.
12. Gorelick, R. J., D. J. Chabot, D. E. Ott, T. D. Gagliardi, A. Rein, L. E. Henderson, and L. O. Arthur. 1996. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid: replacement of zinc-binding residues with other zinc-binding residues yields noninfectious particles containing genomic RNA. J. Virol. 70:2593-2597.
13. Gorelick, R. J., L. E. Henderson, J. P. Hanser, and A. Rein. 1988. Point mutations of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. USA 85:8420-8424.
14. Gorelick, R. J., S. M. Nigida, Jr., J. W. Bess, Jr., L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 46:3207-3211.
15. Henderson, L. E., et al. Unpublished data.
16. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
17. Kosower, N. S., and E. M. Kosower. 1978. The glutathione status of cells. Int. Rev. Cytol. 54:109-160.
18. Lapadat-Tapolsky, M., H. De Rocquigny, D. Van Gent, B. Roques, R. Plasterk, and J.-L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
19. Maurer, B., H. Bannert, G. Darai, and R. M. Flügel. 1988. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1590-1597.
20. Méric, C., and S. P. Goff. 1989. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63:1558-1568.
21. Nagy, K., M. Young, C. Baboonian, J. Merson, P. Whittle, and S. Oroszlan. 1994. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase. J. Virol. 68:757-765.
22. Ott, D., et al. Unpublished results.
23. Ott, D. E., J. Keller, K. Sill, and A. Rein. 1992. Phenotypes of murine leukemia virus-induced tumors: influence of 3′ viral coding sequences. J. Virol. 66:6107-6116.
24. Peliska, J. A., S. Balasubramanian, D. P. Giedroc, and S. J. Benkovic. 1994. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33:13817-13823.
25. Rein, A., D. P. Harvin, J. Mirro, S. M. Ernst, and R. J. Gorelick. 1994. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J. Virol. 68:6124-6129.
26. Rice, W. G., C. A. Sehaeffer, L. Graham, M. Bu, J. S. McDougal, S. L. Orloff, F. Villinger, M. Young, S. Oroszlan, M. R. Fesen, Y. Pommier, J. Mendeleyev, and E. Kun. 1993. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc. Natl. Acad. Sci. USA 90:9721-9724.
27. Rice, W. G., C. A. Schaeffer, B. Harten, F. Villinger, T. L. South, M. F. Summers, L. E. Henderson, J. W. Bess, Jr., L. O. Arthur, J. S. McDongal, S. L. Orloff, J. Mendeleyev, and E. Kun. 1993. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (London) 361:473-475.
28. Rince, W. G., J. G. Supko, L. Malspeis, R. W. Buckheit, Jr., D. Clanton, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, J. Domagala, R. Gogliotti, J. P. Bader, S. M. Halliday, L. Coren, R. C. Sowder II, L. O. Arthur, and L. E. Henderson. 1995. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
29. Roberts, M. M., and S. Oroszlan. 1989. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem. Biophys. Res. Commun. 160:486-494.
30. Rodriguez-Rodriguez, L., Z. Tsuchihashi, G. M. Fuentes, R. A. Bambara, and P. J. Fay. 1995. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J. Biol. Chem. 270:15005-15011.
31. Shinnick, T. M., R. A. Lernen, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukemia virus. Nature (London) 293:543-548.
32. Summers, M. F., L. E. Henderson, M. R. Chance, J. W. Bess, Jr., T. L. South, P. R. Blake, I. Sagi, G. Perez-Alvarado, R. C. Sowder III, D. R. Hare, and L. O. Arthur. 1993. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1:563-574.
33. Turpin, J. A., S. J. Terpening, C. A. Schaeffer, G. Yu, C. J. Glover, R. L. Felsted, E. A. Sausville, and W. G. Rice. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. J. Virol., in press.
34. Versteegen, R. J., and S. Oroszlan. 1980. Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses. J. Virol. 33:983-992.
35. Wondrak, E. M., K. Sakaguchi, W. G. Rice, E. Kun, A. R. Kimmel, and J. M. Louis. 1994. Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease. J. Biol. Chem. 269:21948-21950.
36. Wu, W., L. E. Henderson, T. D. Copeland, R. J. Gorelick, W. J. Bosche, A. Rein, and J. G. Levin. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. Submitted for publication.
37. You, J. C., and C. S. McHenry, 1994. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269:31491-31495.
38. Yu, S. F., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
39. Yu, S. F., and M. L. Linial. 1993. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J. Virol. 67:6618-6624.